Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing ...
Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.